Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

CUSIP: 03209R103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
33,557,586
Share change
+933,080
Total reported value
$898,632,046
Put/Call ratio
0%
Price per share
$26.78
Number of holders
232
Value change
+$25,047,300
Number of buys
115
Number of sells
118

Quarterly Holders Quick Answers

What is CUSIP 03209R103?
CUSIP 03209R103 identifies AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Jack Y. Zhang
13D/G
25%
12,524,153
$301,456,363 $0 31 Dec 2024
BlackRock, Inc.
13F 13D/G
Company
12%
from 13D/G
5,485,057
$146,176,770 30 Sep 2025
VANGUARD GROUP INC
13F
Company
5.7%
2,631,040
$70,117,216 30 Sep 2025
13F
Mary Z. Luo
3/4/5
COO,Chief Scientist & Chairman, Director, 10%+ Owner
class O/S missing
1,109,416
$63,239,930 10 Jan 2024
TD ASSET MANAGEMENT INC
13F
Company
4.2%
1,931,892
$51,484,922 30 Sep 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.8%
1,755,665
$46,789,114 30 Sep 2025
13F
STATE STREET CORP
13F
Company
3.2%
1,500,742
$39,994,774 30 Sep 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
2.9%
1,353,927
$36,082,167 30 Sep 2025
13F
Boston Trust Walden Corp
13F
Company
2.5%
1,173,107
$31,263,302 30 Sep 2025
13F
Epoch Investment Partners, Inc.
13F
Company
2.4%
1,133,986
$30,220,727 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
922,577
$24,590,067 30 Sep 2025
13F
MARSHALL WACE, LLP
13F
Company
1.9%
874,068
$23,293,911 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.5%
697,765
$18,595,437 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.3%
586,900
$15,640,885 30 Sep 2025
13F
Richard Koo
3/4/5
Director
mixed-class rows
286,471
mixed-class rows
$15,350,254 07 Jun 2021
MORGAN STANLEY
13F
Company
1.2%
574,679
$15,315,209 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.1%
517,222
$13,783,966 30 Sep 2025
13F
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
0.91%
423,112
$11,275,974 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.86%
399,470
$10,645,876 30 Sep 2025
13F
ALGERT GLOBAL LLC
13F
Company
0.85%
392,902
$10,471,000 30 Sep 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.85%
392,310
$10,455,062 30 Sep 2025
13F
Invesco Ltd.
13F
Company
0.84%
389,593
$10,382,654 30 Sep 2025
13F
ROYCE & ASSOCIATES LP
13F
Company
0.79%
366,322
$9,762,481 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.77%
356,409
$9,498,300 30 Sep 2025
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.7%
326,183
$8,692,777 30 Sep 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.67%
312,337
$8,323,781 30 Sep 2025
13F
UBS Group AG
13F
Company
0.67%
312,274
$8,322,102 30 Sep 2025
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.63%
292,443
$7,793,606 30 Sep 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.62%
288,585
$7,690,790 30 Sep 2025
13F
Clark Capital Management Group, Inc.
13F
Company
0.61%
283,674
$7,559,912 30 Sep 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.59%
275,222
$7,336,000 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.58%
267,828
$7,137,617 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.55%
253,232
$6,748,633 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.52%
241,228
$6,428,726 30 Sep 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.52%
241,212
$6,428,300 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.49%
226,775
$6,043,554 30 Sep 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.48%
222,019
$5,916,806 30 Sep 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.46%
211,800
$5,644,471 30 Sep 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.44%
205,678
$5,481,318 30 Sep 2025
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.33%
153,351
$4,091,405 30 Sep 2025
13F
FIRST TRUST ADVISORS LP
13F
Company
0.32%
150,422
$4,008,746 30 Sep 2025
13F
Empowered Funds, LLC
13F
Company
0.32%
149,795
$3,992,037 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.32%
148,459
$3,956,432 30 Sep 2025
13F
Howard Lee
3/4/5
Director
mixed-class rows
163,378
mixed-class rows
$3,952,895 02 Jun 2025
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.31%
141,852
$3,780,356 30 Sep 2025
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
0.3%
139,675
$3,722,339 30 Sep 2025
13F
Bridge City Capital, LLC
13F
Company
0.29%
136,258
$3,631,276 30 Sep 2025
13F
DENALI ADVISORS LLC
13F
Company
0.29%
135,000
$3,597,750 30 Sep 2025
13F
LAM GROUP, INC.
13F
Company
0.28%
130,800
$3,485,820 30 Sep 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.28%
129,841
$3,460,263 30 Sep 2025
13F

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2025

As of 31 Dec 2025, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 232 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,557,586 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, TD Asset Management Inc, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, FULLER & THALER ASSET MANAGEMENT, INC., MARSHALL WACE, LLP, Epoch Investment Partners, Inc., Boston Trust Walden Corp, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 232 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
240
Q4 2025 holders
232
Holder diff
-8
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .